These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35441731)

  • 21. Risk factors for nephropathy in persons with type 1 diabetes: a population-based study.
    Seyed Ahmadi S; Pivodic A; Svensson AM; Wedel H; Rathsman B; Nyström T; Ludvigsson J; Lind M
    Acta Diabetol; 2022 Jun; 59(6):761-772. PubMed ID: 35201418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.
    Carrington MJ; Zimmet P
    BMC Health Serv Res; 2017 Dec; 17(1):813. PubMed ID: 29212477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control and complications of diabetes in urban primary care units in Thailand: a cross-sectional study.
    Puangpet T; Pongkunakorn T; Chulkarat N; Bunlangjit C; Surawit A; Pinsawas B; Mongkolsucharitkul P; Mayurasakorn K
    BMC Prim Care; 2022 Aug; 23(1):212. PubMed ID: 35996081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
    de Ritter R; Sep SJS; van der Kallen CJH; Schram MT; Koster A; Kroon AA; van Greevenbroek MMJ; Eussen SJPM; Dagnelie PC; de Jong M; Vos RC; Woodward M; Bots ML; Peters SAE; Stehouwer CDA
    BMJ Open Diabetes Res Care; 2019; 7(1):e000787. PubMed ID: 31798903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles.
    O'Neal DN; Piers LS; Iser DM; Rowley KG; Jenkins AJ; Best JD; O'Dea K
    Atherosclerosis; 2008 Dec; 201(2):368-77. PubMed ID: 18599067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations with sight-threatening diabetic macular oedema among Indigenous adults with type 2 diabetes attending an Indigenous primary care clinic in remote Australia: a Centre of Research Excellence in Diabetic Retinopathy and Telehealth Eye and Associated Medical Services Network study.
    Brazionis L; Keech A; Ryan C; Brown A; O'Neal D; Boffa J; Bursell SE; Jenkins A
    BMJ Open Ophthalmol; 2021; 6(1):e000559. PubMed ID: 34307891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model of culturally-informed integrated diabetes education and eye screening in indigenous primary care services and specialist diabetes clinics: Study protocol.
    Atkinson-Briggs S; Jenkins A; Keech A; Ryan C; Brazionis L;
    J Adv Nurs; 2021 Mar; 77(3):1578-1590. PubMed ID: 33426727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline treatments and metabolic control of 288,913 type 2 diabetes patients in a 10-year retrospective cohort in Malaysia.
    Wan KS; Mustapha F; Chandran A; Ganapathy SS; Zakariah N; Ramasamy S; Subbarao GR; Mohd Yusoff MF
    Sci Rep; 2023 Oct; 13(1):17338. PubMed ID: 37833402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of an eight-week supervised, structured lifestyle modification programme on anthropometric, metabolic and cardiovascular risk factors in severely obese adults.
    Crowe C; Gibson I; Cunningham K; Kerins C; Costello C; Windle J; O Shea PM; Hynes M; McGuire B; Kilkelly K; Griffin H; O Brien T; Jones J; Finucane FM
    BMC Endocr Disord; 2015 Aug; 15():37. PubMed ID: 26231181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Homocysteine and C-reactive protein concentrations in serum of diabetic patients].
    Idzior-Waluś B; Cieślik G; Waluś M; Sieradzki J
    Przegl Lek; 2003; 60(12):778-81. PubMed ID: 15058015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of diabetes in indigenous Australians from primary care.
    Thomas M; Weekes AJ; Thomas MC
    BMC Public Health; 2007 Oct; 7():303. PubMed ID: 17958918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classical cardiovascular risk factors in Trinidadian patients with type 2 diabetes mellitus are not influenced by the level of plasma glycaemia.
    Ezenwaka CE; Offiah NV
    West Indian Med J; 2001 Dec; 50(4):288-93. PubMed ID: 11993019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Diabetes Education in Adults With Diabetes Mellitus Type 2 in Primary Care: A Systematic Review.
    Cruz-Cobo C; Santi-Cano MJ
    J Nurs Scholarsh; 2020 Mar; 52(2):155-163. PubMed ID: 31912967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.
    Petitti DB; Imperatore G; Palla SL; Daniels SR; Dolan LM; Kershnar AK; Marcovina S; Pettitt DJ; Pihoker C;
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):159-65. PubMed ID: 17283301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.
    Lim LL; Lau ESH; Fu AWC; Ray S; Hung YJ; Tan ATB; Chamnan P; Sheu WHH; Chawla MS; Chia YC; Chuang LM; Nguyen DC; Sosale A; Saboo BD; Phadke U; Kesavadev J; Goh SY; Gera N; Huyen Vu TT; Ma RCW; Lau V; Luk AOY; Kong APS; Chan JCN;
    JAMA Netw Open; 2021 Apr; 4(4):e217557. PubMed ID: 33929522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.
    Alzubaidi HT; Chandir S; Hasan S; McNamara K; Cox R; Krass I
    BMJ Open; 2019 Nov; 9(11):e031246. PubMed ID: 31712336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.